Xiaowen Ding
Impact in
-
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
-
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 9
- Oncology 13
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 4
Xiaowen Ding
25 papers receiving 312 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 114
- Oncology 99
- Reproductive Medicine 17
- Biomaterials 22
- Molecular Biology 99
Countries citing papers authored by Xiaowen Ding
This map shows the geographic impact of Xiaowen Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowen Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowen Ding more than expected).
Fields of papers citing papers by Xiaowen Ding
This network shows the impact of papers produced by Xiaowen Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowen Ding. The network helps show where Xiaowen Ding may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaowen Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 6 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 19 | |
| 12 | 2020 | 25 | |
| 13 | 2020 | 4 | |
| 14 | 2019 | 1 | |
| 15 | 2018 | 32 | |
| 16 | 2017 | 62 | |
| 17 | 2015 | 7 | |
| 18 | 2013 | 12 | |
| 19 | 2013 | 15 | |
| 20 | 2011 | 6 |
About Xiaowen Ding
Xiaowen Ding is a scholar working on Cancer Research, Oncology, Biological Psychiatry, Behavioral Neuroscience and Genetics, having authored 28 papers that have together received 316 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), HER2/EGFR in Cancer Research (7 papers), Advanced Breast Cancer Therapies (4 papers), Cancer Treatment and Pharmacology (4 papers), RNA modifications and cancer (3 papers), Estrogen and related hormone effects (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Cancer Research (114 citations), Oncology (99 citations), Reproductive Medicine (17 citations), Biomaterials (22 citations) and Molecular Biology (99 citations). Xiaowen Ding has collaborated with scholars based in China, Macao and Singapore. Frequent co-authors include Xiping Zhang, Xianfeng Ding, Yuqin Ding, Xiangming He, Ming Zhao, Hongjian Yang, Dehong Zou, Guangzhong Chen, Dong Zhou and Chao Peng. Their work appears in journals such as PLoS ONE, Journal of Clinical Oncology, Oncotarget, Chinese Journal of Chemistry and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.